author-photo

Martínez-Piñeiro Ja

Autonomous University of Madrid

147

Papers

2331

Citations

Citation Trend

Filter By

Papers (147) Sort By

Journal Conference Others

Estudio retrospectivo de diferentes opciones de tratamiento conservador con Bacilo de Calmette-Guèrin en el carcinoma urotelial vesical T1G3: terapia de mantenimiento

2016 Actas Urologicas Espanolas
Show All
- Source
- Cite
- Save
Citations (10)
Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapy.

2016 Actas Urologicas Espanolas
Show All
- Source
- Cite
- Save
Citations (6)
Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

2015 European Urology
Show All
- Source
- Cite
- Save
Citations (50)
Influencia del número real de instilaciones de Bacilo de Calmette-Guérin aplicadas en el pronóstico de los tumores vesicales no músculo-infiltrantes

2014 Actas Urologicas Espanolas
Show All
- Source
- Cite
- Save
Citations (3)
Influence of the true number of Bacillus Calmette-Guérin instillations on the prognosis of non-muscle invasive bladder tumors

2014 Actas Urologicas Espanolas
Show All
- Source
- Cite
- Save
Citations (2)
702 Is there any influence on the real number of BCG instillations applied on the outcome of high-grade non-muscle-invasive bladder cancer (NMIBC)?

2013 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (1)
The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

2011 European Urology
Show All
- Source
- Cite
- Save
Citations (137)
188 TREATMENT OF CARCINOMA IN SITU OF THE BLADDER ASSOCIATED OR NOT ASSOCIATED TO NON-MUSCLE INVASIVE TRANSITIONAL CARCINOMA USING TWO DIFFERENT BCG DOSES: THE STANDARD OR ONE-THIRD DOSE. A FIVE YEAR FOLLOW-UP

2010 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (4)
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

2009 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (373)
PREDICTION OF RECURRENCE AND PROGRESSION OF NON- MUSCLE INVASIVE BLADDER CANCER IN PATIENTS TREATED WITH BACILLUS CALMETTE-GUÉRIN: A SCORING SYSTEM BASED ON MULTIVARIATE ANALYSIS OF DATA FROM FOUR RANDOMISED CUETO TRIALS

2008 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (2)